BR0318319A - métodos de preparação e formulações/composições sustentadas pelo uso de dimeticona como veìculo - Google Patents

métodos de preparação e formulações/composições sustentadas pelo uso de dimeticona como veìculo

Info

Publication number
BR0318319A
BR0318319A BRPI0318319-0A BR0318319A BR0318319A BR 0318319 A BR0318319 A BR 0318319A BR 0318319 A BR0318319 A BR 0318319A BR 0318319 A BR0318319 A BR 0318319A
Authority
BR
Brazil
Prior art keywords
dimethicone
formulation
sustained
formulations
vehicle
Prior art date
Application number
BRPI0318319-0A
Other languages
English (en)
Inventor
Yuwan Wang
Zhende Pan
Xiaoxi Dai
Original Assignee
Yuwan Wang
Eco Animal Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN 03148883 external-priority patent/CN1565445A/zh
Priority claimed from CNA031535690A external-priority patent/CN1533764A/zh
Priority claimed from CNB031568769A external-priority patent/CN1256948C/zh
Application filed by Yuwan Wang, Eco Animal Health Ltd filed Critical Yuwan Wang
Publication of BR0318319A publication Critical patent/BR0318319A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Abstract

"MéTODOS DE PREPARAçãO E FORMULAçõES/COMPOSIçõES SUSTENTADAS PELO USO DE DIMETICONA COMO VEìCULO". A presente invenção diz respeito à preparação de formulação sustentada pelo uso de dimeticona como veículo. A referida formulação consiste em ingrediente ativo (por exemplo, medicamentos contra parasitas, inseticidas, NSAIDs, antibióticos, agentes semelhantes a hormónio sexual ou vitaminas oleosas solúveis) 0,5~40% (P/V) , dimeticona 100% (V/V). Também podem ser adicionados um estabilizador adequado, um antioxidante, analgésicos locais e material para a liberação sustentada. A formulação que compreende agentes de abamectinas contra parasites, que é preparada com dimeticona como meio, pode fornecer ação duradoura de até 50-120 dias por injeção subcutânea em uma única administração. O período de duração pode ser modificado pelo ajuste da dosagem de administração. A formulação de acordo com a presente invenção é biocompatível, estável e injetável.
BRPI0318319-0A 2003-05-25 2003-10-08 métodos de preparação e formulações/composições sustentadas pelo uso de dimeticona como veìculo BR0318319A (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN03138019 2003-05-25
CN 03148883 CN1565445A (zh) 2003-06-16 2003-06-16 含n－苯基吡唑类药物的兽用长效注射剂
CNA031535690A CN1533764A (zh) 2003-04-02 2003-08-18 含非甾体抗炎药物的缓释注射剂
CNB031568769A CN1256948C (zh) 2003-05-25 2003-09-11 含阿维菌素类抗寄生虫药物的长效注射剂
PCT/CN2003/000849 WO2004103343A1 (fr) 2003-05-25 2003-10-08 Formulation a liberation prolongee a base de dimethicone

Publications (1)

Publication Number Publication Date
BR0318319A true BR0318319A (pt) 2006-07-18

Family

ID=33479733

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0318319-0A BR0318319A (pt) 2003-05-25 2003-10-08 métodos de preparação e formulações/composições sustentadas pelo uso de dimeticona como veìculo

Country Status (6)

Country Link
US (1) US7648711B2 (pt)
EP (1) EP1634584A1 (pt)
AU (1) AU2003275509A1 (pt)
BR (1) BR0318319A (pt)
MX (1) MXPA05012791A (pt)
WO (1) WO2004103343A1 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
AU2003279493B2 (en) 2002-10-25 2009-08-20 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
BRPI0705822A2 (pt) * 2007-10-25 2009-06-23 Schering Plough Saude Animal Ltda formulação injetável com ação prolongada e uso de um agente semi-sintético derivado do grupo das avermectinas, em combinação com um polìmero biodegradável
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
US9820977B2 (en) 2008-10-03 2017-11-21 Bayer Healthcare Llc Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent
CA2760186C (en) 2009-04-28 2019-10-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
MX359879B (es) 2009-10-02 2018-10-12 Foamix Pharmaceuticals Ltd Composiciones tópicas de tetraciclina.
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US20130053353A1 (en) * 2010-05-04 2013-02-28 Foamix Ltd. Compositions, gels and foams with rheology modulators and uses
EP2699267A4 (en) * 2011-04-18 2014-11-12 Lipidor Ab LIQUID CARRIER FOR THE ORAL DELIVERY OF A PHARMACOLOGICAL ACTIVE SUBSTANCE
FR3000400B1 (fr) * 2012-12-27 2019-06-21 Virbac Suspension huileuse de metronidazole
CN103142458B (zh) 2013-01-22 2015-09-09 莱普德制药有限公司 无成瘾性镇痛缓释递药系统的组方与制备方法
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
CN108261410B (zh) * 2016-12-30 2020-10-27 武汉回盛生物科技股份有限公司 一种酒石酸泰万菌素包合肠溶制剂及制备方法
BR102017010598A2 (pt) 2017-05-19 2018-12-04 Flavio Alves Da Rocha composições veterinárias de liberação retardada para controle de ovos e larvas de helmintos nas fezes dos ruminantes, uso das composições, uso de antelmínticos com essa finalidade
CN110420184A (zh) * 2019-09-16 2019-11-08 上海欣峰制药有限公司 一种注射用头孢米诺钠制剂及其制备和使用方法
CN110478317A (zh) * 2019-09-16 2019-11-22 上海欣峰制药有限公司 一种注射用头孢噻肟钠制剂及其制备方法和悬浮液
CN110507615A (zh) * 2019-09-16 2019-11-29 上海欣峰制药有限公司 一种注射用头孢地嗪钠制剂及其制备和使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
ES2131515T3 (es) * 1991-09-30 1999-08-01 Merck & Co Inc Formulados inyectables de accion prolongada que contienen aceite de ricino hidrogenado.
DE4409357C2 (de) * 1994-03-18 1996-10-17 Upmeyer Hans Juergen Verwendung von Dimeticon zur Eradikation von Heliobacter pylori
JP2001342138A (ja) * 2000-05-31 2001-12-11 Yoshiaki Nagaura ウィルスを不活化する方法
WO2004093886A1 (en) * 2003-04-24 2004-11-04 Galderma S.A. Topical formulation of ivermectin for the treatment of dermatological conditions

Also Published As

Publication number Publication date
AU2003275509A1 (en) 2004-12-13
MXPA05012791A (es) 2006-02-22
WO2004103343A1 (fr) 2004-12-02
US7648711B2 (en) 2010-01-19
EP1634584A1 (en) 2006-03-15
US20070053943A1 (en) 2007-03-08

Similar Documents

Publication Publication Date Title
BR0318319A (pt) métodos de preparação e formulações/composições sustentadas pelo uso de dimeticona como veìculo
ES2308045T3 (es) Composiciones fungicidas, lubricantes de calentamiento y no irritantes en la forma de un gel.
RU2754846C1 (ru) Обезболивающие композиции местного действия
AU2010257466B2 (en) Epidermal growth factor composition, a process therefor and its application
US20030082226A1 (en) Non-steroidal antiinflammatory drug formulations for topical application to the skin
CN101014319B (zh) 液体贮库制剂
AU2003205887B2 (en) Long acting parasiticidal composition containing a salicylanilide compound, a polymeric species and at least one other anti-parasitic compound
CA2336682A1 (en) Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof
BR0312007A (pt) Controle de taxa de administração transcutânea usando composições farmacêuticas amorfas
PT503988E (pt) Composicoes para o tratamento de onicomicoses
RS53127B (en) STABLE PROTEIN FORMULATIONS
CY1111874T1 (el) Ενεσιμη χορηγηση αριπιπραζολης
BRPI0418098A (pt) formulações veterinárias não contendo produtos animais
PT1522219E (pt) FORMULAÎES ANTIPARASITáRIAS
US20080138391A1 (en) Skin-friendly drug complexes for transdermal administration
HUP0302452A2 (hu) Prosztaglandin E1-et tartalmazó topikus gyógyászati készítmények
MXPA04009819A (es) Reduccion de crecimiento de vello.
KR20100038118A (ko) 체내구충 국소 조성물
CN104797252A (zh) 减轻噪音厌恶的兽医方法
JP7103752B2 (ja) 疼痛、掻痒症および炎症のためのストロンチウムをベースとする組成物および製剤
DE69229318T2 (de) Hydrierte Rizinusöl-enthaltende injizierbare Formulierungen mit verlängerter Wirkstoffabgabe
PE20060908A1 (es) Composicion antihelmintica
MXPA05013270A (es) Forma de administracion transmucosal con irritacion mucosal reducida. reducida.
PT1305057E (pt) Composicao de biomateria microparticular para uso medicinal
US20170232026A1 (en) Pharmaceutical composition in ivermectin emulgel for veterinary use as a promoter system and bio-adhesive in antiparasitic treatment, and method for the production thereof

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A E 7A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2073 DE 28/09/2010.